Nostrum Biodiscovery joins Barcelona Science Park Blog Post

Nostrum Biodiscovery, a spin-off created thanks to the transfer of technology from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), has moved to Barcelona Science Park. Combining its own technologies with the best modelling software on the market, the company provides in silico services to pharmaceutical and biotechnology companies to accelerate and optimise the design of therapeutic molecules and enzymes, and overcome the common “bottlenecks” in the most initial stages of drug discovery.

 

IBEC obtains a second accreditation as Severo Ochoa Centre of Excellence Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, is one of the six centres in Spain to be awarded accreditation in this round of the Severo Ochoa Excellence programme. Furthermore, IBEC is the only center that receives this accreditation for the second time. The awards last for four years and bring a million euros each year to the winning centres, it also implies strengthening research capacities and boosting success rates in other competitive funding programmes.

 

Núria Montserrat represents the European Research Council at the WEF Summer Davos in China Blog Post

Núria Montserrat, ICREA professor and principal investigator at the Institute for Bioengineering of Catalonia (IBEC) was among the nine scientists representatives of the European Research Council (ERC) at the Annual Meeting of the New Champions (AMNC), also known as “Summer Davos“. Organised by the World Economic Forum (WEF) in the Chinese city of Dailan from 1 to 3 July, the 2019 edition of this event brought together the brightest minds on the planet to discuss issues related to scientific research, leadership, and innovation. 

 

The MessyCheffy project won the challenge launched by the PCB, the IBEC and the IRB in the iFest Countdown Blog Post

MessyCheffy, an interactive physiotherapy game for children with muscular dystrophy, developed by the Yallow team from the University of Barcelona, has won the “Rare Diseases” challenge set by the Barcelona Science Park, the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona) as part of the iFest Countdown initiative. The young finalists of this programme presented their prototypes to a panel at the Auditorium Imagina Mediapro today at the iFest Demo Day, during an event chaired by the director of Catalunya Emprèn, Pere Condom. 

 

The BSC-IRB researcher Toni Gabaldón, vice president of the new Young Academy of Spain Blog Post

The Young Academy of Spain has been constituted today in the Ministry of Science, Innovation and Universities with the aim of representing and giving visibility to young scientists, preferably from the field of experimental sciences. One of the founding members and vice president of this new scientific institution is ICREA researcher Toni Gabaldón, with double affiliation to the Barcelona Supercomputing Center (BSC-CNS) and IRB Barcelona, leading the Comparative Genomics group.

 

World’s first baby is born in Greece through of Maternal Spindle Transfer technique developed by Embryotools Blog Post

Through pioneering clinical research, Embryotools, based in the Barcelona Science Park, and Institute of Life in Athens have achieveg birth of the world’s first healthy baby through the pioneering Maternal Spindle Transfer method to solve infertility problems. This technique was implemented by the Greek IVF center and Spanish research center to address fertility issues associated with multiple in vitro fertilization (IVF) failures caused by cytoplasmic dysfunction of the oocytes or rare mitochondrial genetic diseases.

 

Hipra opens an R&D centre at the Barcelona Science Park Blog Post

Hipra, the multinational company dedicated to the research, production and marketing of animal health products, has opened an R&D centre at the Barcelona Science Park (PCB). The company from Girona (Spain) is one of the world’s leading veterinary vaccine and biological medicine companies and boasts more than thirty subsidiaries across the globe.